Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
46.44
+1.63 (3.65%)
At close: Apr 14, 2026, 4:00 PM EDT
46.44
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:15 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are Moderna stock at 8.45%, Arrowhead Pharmaceuticals at 6.62%, Praxis Precision Medicines at 6.61%, Illumina at 5.21%, and Guardant Health at 4.45%.
Total Holdings
50
Top 10 Percentage
51.47%
Asset Class
Equity
ETF Category
Health
Assets
50.47M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 8.45% |
| 2 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.62% |
| 3 | PRAX | Praxis Precision Medicines, Inc. | 6.61% |
| 4 | ILMN | Illumina, Inc. | 5.21% |
| 5 | GH | Guardant Health, Inc. | 4.45% |
| 6 | BMRN | BioMarin Pharmaceutical Inc. | 4.30% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 4.28% |
| 8 | NTRA | Natera, Inc. | 4.10% |
| 9 | BNTX | BioNTech SE | 3.78% |
| 10 | TECH | Bio-Techne Corporation | 3.67% |
| 11 | QGEN | Qiagen N.V. | 3.37% |
| 12 | CRSP | CRISPR Therapeutics AG | 3.35% |
| 13 | BMY | Bristol-Myers Squibb Company | 2.82% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.74% |
| 15 | TWST | Twist Bioscience Corporation | 2.65% |
| 16 | LON: AZN | AstraZeneca PLC | 2.52% |
| 17 | TXG | 10x Genomics, Inc. | 2.47% |
| 18 | BEAM | Beam Therapeutics Inc. | 2.40% |
| 19 | GILD | Gilead Sciences, Inc. | 2.40% |
| 20 | LLY | Eli Lilly and Company | 2.36% |
| 21 | LEGN | Legend Biotech Corporation | 2.31% |
| 22 | VCYT | Veracyte, Inc. | 2.29% |
| 23 | RARE | Ultragenyx Pharmaceutical Inc. | 2.00% |
| 24 | SRPT | Sarepta Therapeutics, Inc. | 1.88% |
| 25 | HKG: 1548 | Genscript Biotech Corporation | 1.76% |
As of Apr 10, 2026